Martens AWJ - Search Results

1

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas.

Martens AWJ, Rietveld JM, de Boer R, Peters FS, Ngo A, van Mil LWHG, de Heer K, Spaargaren M, Verkleij CPM, van de Donk NWCJ, Adams HC 3rd, Eldering E, van Noesel CJM, Verona R, Kater AP. Martens AWJ, et al. Cancer Res Commun. 2022 May 9;2(5):330-341. doi: 10.1158/2767-9764.CRC-22-0083. eCollection 2022 May. Cancer Res Commun. 2022. PMID: 36875718 Free PMC article.

2

Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8⁺ T cells and impede CAR T-cell efficacy.

van Bruggen JAC, Martens AWJ, Fraietta JA, Hofland T, Tonino SH, Eldering E, Levin MD, Siska PJ, Endstra S, Rathmell JC, June CH, Porter DL, Melenhorst JJ, Kater AP, van der Windt GJW. van Bruggen JAC, et al. Among authors: martens awj. Blood. 2019 Jul 4;134(1):44-58. doi: 10.1182/blood.2018885863. Epub 2019 May 10. Blood. 2019. PMID: 31076448 Free PMC article.

3

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells.

Martens AWJ, Janssen SR, Derks IAM, Adams Iii HC, Izhak L, van Kampen R, Tonino SH, Eldering E, van der Windt GJW, Kater AP. Martens AWJ, et al. J Immunother Cancer. 2020 Jun;8(1):e000218. doi: 10.1136/jitc-2019-000218. J Immunother Cancer. 2020. PMID: 32581054 Free PMC article.

4

Human CXCR5⁺ PD-1⁺ CD8 T cells in healthy individuals and patients with hematologic malignancies.

Hofland T, Martens AWJ, van Bruggen JAC, de Boer R, Schetters S, Remmerswaal EBM, Bemelman FJ, Levin MD, Bins AD, Eldering E, Kater AP, Tonino SH. Hofland T, et al. Among authors: martens awj. Eur J Immunol. 2021 Mar;51(3):703-713. doi: 10.1002/eji.202048761. Epub 2020 Nov 23. Eur J Immunol. 2021. PMID: 33098668 Free PMC article.

5

Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma.

van Bruggen JAC, Martens AWJ, Tonino SH, Kater AP. van Bruggen JAC, et al. Among authors: martens awj. Cancers (Basel). 2020 Dec 18;12(12):3837. doi: 10.3390/cancers12123837. Cancers (Basel). 2020. PMID: 33353234 Free PMC article. Review.

6

Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia.

Kater AP, Slinger E, Cretenet G, Martens AW, Balasubramanian S, Leverson JD, Eldering E. Kater AP, et al. Blood Adv. 2021 Dec 14;5(23):5410-5414. doi: 10.1182/bloodadvances.2021004861. Blood Adv. 2021. PMID: 34555843 Free PMC article.

7

Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837.

van Bruggen JAC, Martens AWJ, Tonino SH, Kater AP. van Bruggen JAC, et al. Among authors: martens awj. Cancers (Basel). 2021 Sep 22;13(19):4738. doi: 10.3390/cancers13194738. Cancers (Basel). 2021. PMID: 34638518 Free PMC article.

8

T-cell subset composition and functionality in patients with Waldenström's macroglobulinemia.

Amaador K, Martens A, de Boer R, Rietveld J, Heemskerk M, Rutten CE, Eldering E, Kersten MJ, Kater AP, Vos J, Tonino S. Amaador K, et al. Leuk Lymphoma. 2022 Jun;63(6):1469-1473. doi: 10.1080/10428194.2022.2030478. Epub 2022 Feb 1. Leuk Lymphoma. 2022. PMID: 35105260 No abstract available.

9

Chronic lymphocytic leukemia presence impairs antigen-specific CD8⁺ T-cell responses through epigenetic reprogramming towards short-lived effectors.

Martens AWJ, Kavazović I, Krapić M, Pack SM, Arens R, Jongejan A, Moerland PD, Eldering E, van der Windt GJW, Wensveen FM, Peters FS, Kater AP. Martens AWJ, et al. Leukemia. 2023 Mar;37(3):606-616. doi: 10.1038/s41375-023-01817-z. Epub 2023 Jan 19. Leukemia. 2023. PMID: 36658390 Free PMC article.

10

Serpin B9 controls tumor cell killing by CAR T cells.

Kimman T, Slomp A, Martens A, Grabherr S, Li S, van Diest E, Meeldijk J, Kuball J, Minnema MC, Eldering E, Bovenschen N, Sebestyén Z, Peperzak V. Kimman T, et al. J Immunother Cancer. 2023 Mar;11(3):e006364. doi: 10.1136/jitc-2022-006364. J Immunother Cancer. 2023. PMID: 36931661 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page